Liang et al., 2022 - Google Patents
Modeling human thyroid development by fetal tissue‐derived organoid cultureLiang et al., 2022
View HTML- Document ID
- 4097705680022327193
- Author
- Liang J
- Qian J
- Yang L
- Chen X
- Wang X
- Lin X
- Wang X
- Zhao B
- Publication year
- Publication venue
- Advanced Science
External Links
Snippet
Euthyroidism is of profound importance for lifetime health. However, the early diagnosis or therapeutics of thyroid developmental defects has not been established, mainly due to limited understanding of human thyroid development and a lack of recapitulating research …
- 210000001685 Thyroid Gland 0 title abstract description 206
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Liang et al. | Modeling human thyroid development by fetal tissue‐derived organoid culture | |
Zeng et al. | Generation of patterned kidney organoids that recapitulate the adult kidney collecting duct system from expandable ureteric bud progenitors | |
Peng et al. | Inflammatory cytokine TNFα promotes the long-term expansion of primary hepatocytes in 3D culture | |
Collin et al. | CRX expression in pluripotent stem cell-derived photoreceptors marks a transplantable subpopulation of early cones | |
Jaremek et al. | Omics approaches to study formation and function of human placental syncytiotrophoblast | |
Hwang et al. | Global increase in replication fork speed during a p57KIP2-regulated erythroid cell fate switch | |
Wang et al. | Functional antagonism between ΔNp63α and GCM1 regulates human trophoblast stemness and differentiation | |
Mevel et al. | RUNX1 marks a luminal castration-resistant lineage established at the onset of prostate development | |
Song et al. | Targeting APLN/APJ restores blood-testis barrier and improves spermatogenesis in murine and human diabetic models | |
Westerling-Bui et al. | Transplanted organoids empower human preclinical assessment of drug candidate for the clinic | |
Cheng et al. | Shp2 in uterine stromal cells critically regulates on time embryo implantation and stromal decidualization by multiple pathways during early pregnancy | |
Shui et al. | Advances in neuroendocrine prostate cancer research: From model construction to molecular network analyses | |
Correra et al. | The imprinted gene Pw1/Peg3 regulates skeletal muscle growth, satellite cell metabolic state, and self-renewal | |
Brucker et al. | Endometrial organoids derived from Mayer–Rokitansky–Küster–Hauser syndrome patients provide insights into disease-causing pathways | |
Liang et al. | Inhibiting stromal Class I HDACs curbs pancreatic cancer progression | |
Okafor et al. | Single-cell chromatin accessibility profiling reveals a self-renewing muscle satellite cell state | |
Shintani et al. | Isolation of PRRX1-positive adult pituitary stem/progenitor cells from the marginal cell layer of the mouse anterior lobe | |
Lin et al. | ETS1 loss in mice impairs cardiac outflow tract septation via a cell migration defect autonomous to the neural crest | |
Jiang et al. | ECSIT is a critical factor for controlling intestinal homeostasis and tumorigenesis through regulating the translation of YAP protein | |
Roos et al. | Single-cell RNA-seq analysis and cell-cluster deconvolution of the human preovulatory follicular fluid cells provide insights into the pathophysiology of ovarian hyporesponse | |
Dong et al. | Integrated MicroRNA and secretome analysis of human endometrial organoids reveal the miR-3194-5p/aquaporin/S100A9 module in regulating trophoblast functions | |
Byrnes et al. | Opposing transcription factors MYCL and HEY1 mediate the Notch-dependent airway stem cell fate decision | |
Scagliotti et al. | Imprinted Dlk1 dosage as a size determinant of the mammalian pituitary gland | |
Yang et al. | SFRP2 modulates functional phenotype transition and energy metabolism of macrophages during diabetic wound healing | |
Ngan et al. | Modeling lung cell development using human pluripotent stem cells |